Category: Breast Cancer

Everything Genetic launches new breast cancer genetic risk panel

We are pleased to announce the launch of our own brand 12 Gene Breast Cancer Panel. A germline DNA next-generation sequencing test that is set to revolutionise genetic testing in the UK with its faster results turnaround and lower cost.  This panel provides a comprehensive genetic risk assessment of 12 genes, including BRCA1 and 2,… Read more »

Everything Genetic’s Prosigna® lab is the first in the UK to gain ISO 15189 accreditation

Everything Genetic is pleased to announce that its testing laboratory, the Berkshire and Surrey Pathology Service (BSPS), is now the first UK laboratory to receive ISO 15189 accreditation from the United Kingdom Accreditation Service (UKAS) to perform testing requirements for the Prosigna® breast cancer prognostic gene signature. ISO 15189 is an international standard that certifies… Read more »

Don’t miss this webinar on genomic profiling in early breast cancer

Upcoming Webinar: Genomic Profiles and the Future of Early Breast Cancer Care Date: 25th September 2020     Time: 4.00pm (CEST)  Register now for this upcoming webinar sponsored by our laboratory partner, Veracyte to hear the latest evidence on the clinical utility of the Prosigna® breast cancer prognostic gene signature to support shared treatment decisions. Hear… Read more »

Prognostic testing: How Prosigna can help to prioritise patients for chemotherapy during the coronavirus pandemic

The implications of coronavirus on the treatment of cancer patients in the UK is still unknown. As you will be aware, NHS England has issued two sets of guidance notes on this matter (guidance notes available on NHS England website. These documents clearly prioritise surgical, chemotherapy and radiotherapy procedures into different priority bands. With regard… Read more »